Delivery Order 75A50122D00002-75A50124F61009
Award Date 1/19/24
Potential Completion Date 6/30/24
Potential Value $445K
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The contract, valued at $491,400.00, is for the fill/finish of a Department of Defense AS03 adjuvant under CLIN 1006E. The contract is a Firm Fixed Price, Delivery Order type and does not have a set-aside designation. Glaxosmithkline has been awarded numerous federal contracts and indefinite...
- This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Glaxosmithkline, LLC to provide the acquisition of egg-based influenza master and working seed lots derived from a specific candidate vaccine virus, as well as fill-finish of any existing egg-based influenza vaccines. The order has a ceiling value of $1,650,050.61 and a completion date of February 21, 2026. No set-aside designation was used....
- This federal contract award to Glaxosmithkline, LLC, doing business as Glaxosmithkline, is for the storage and stability testing of bulk lots and final containers of COVID-19 vaccine adjuvant (AS03) on behalf of the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response. The $14,047,403.70 firm fixed price delivery order, which has no set-aside designation, has a performance period through May 21, 2027. Glaxosmithkline, a foreign-owned...
- This is a delivery order issued under the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) Pandemic Influenza Preparedness and Response 2016-2021 contract vehicle. The $2,064,652.60 firm fixed price contract was awarded to Glaxosmithkline, LLC to provide a range of pharmaceutical goods and services, including influenza vaccines, antiviral medications, vaccine adjuvants, and COVID-19 treatments. Glaxosmithkline, a foreign-owned...
- This is a $499,100 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC. The order is for pharmaceutical goods and services under the Pandemic Influenza Preparedness and Response 2016-2021 multiple award contract. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of products to U.S. government agencies including influenza and hepatitis...
- This is a modification to a delivery order contract awarded to GlaxoSmithKline, LLC, a foreign-owned, for-profit pharmaceutical company, by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response. The purpose of this modification is to fund Option Year Two of CLIN 2201, which is for CGMP (Current Good Manufacturing Practice) adjuvant production, either at the clinical or commercial scale, with a quantity of 1 and a unit price of...
- This federal contract award is for the manufacture of one bulk lot of the antigen AS03 on behalf of the Department of Defense Defense Health Agency. The contract was awarded to Glaxosmithkline, LLC, a pharmaceutical company that has provided a range of pharmaceutical goods and services to U.S. government agencies through various federal contracts and grants. The $8,359,043 firm fixed price delivery order is issued under the Pandemic Influenza Preparedness and Response 2016-2021 indefinite...
- This $563,504 firm fixed price delivery order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The order is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract and does not have a...
- This is a $5,509,886.32 firm fixed-price delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to GlaxoSmithKline, LLC, a foreign-owned for-profit pharmaceutical company. The purpose of the contract is to provide storage and stability services for the government's influenza vaccine stockpile. The contract was originally awarded on June 21, 2019 with a period of performance from August 22, 2020 to August 21, 2021. This...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services to GlaxoSmithKline, LLC, a pharmaceutical company, for the supply of a GlaxoSmithKline vaccine for stock. The contract has a ceiling value of $92,136 and a completion date of October 25, 2015. The contract is not set-aside and was issued under GlaxoSmithKline's General Services Administration (GSA) Schedule 61 contract for pharmaceuticals and drugs. GlaxoSmithKline has provided a range of...